ArticleJCO oncology practice2021

Checkpoint Inhibition Therapy in Transplant-Ineligible Relapsed or Refractory Classic Hodgkin Lymphoma.

Samer A Al-Hadidi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.